SARS COVID-19 Antibody Testing
We are pleased to be able to offer antibody testing for SARS COVID-19.
- Antibody testing can help indicate whether you have been exposed to SARS COVID-19. At this time, it is unknown how long and to what extent antibodies protect against reinfection.
- If you are symptomatic or you have a recent known SARS COVID-19 exposure, the best approach is to get a nasal swab test to evaluate for active infection.
- We aim to offer active SARS COVID-19 infection testing in the near future so please check back soon for updates.
We are also available for consultation regarding strategies for boosting one’s immune system during these stressful times.
Quantitative Antibody Test
This test is intended as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2 (COVID-19), indicating recent or prior infection. The results of this semi-quantitative test should not be interpreted as an indication of degree of immunity or protection from reinfection.
Individuals who have been vaccinated with a SARS-CoV-2 spike or receptor-binding domain vaccine may be positive with this test; however, the clinical significance of a positive antibody result for individuals who have received a COVID-19 vaccine is unknown, in part because the test’s performance characteristics have not been established for that population. It is not known how long antibodies persist following infection and if the presence of antibodies confers protective immunity. This assay should not be used to diagnose acute SARS-CoV-2 infection.
COVID-19 Antibody Testing Options
1. Rapid finger-prick test that provides results in 15 minutes – cost $69
2. Quantitative Antibody Test – results in 2-3 business days – cost $130
Due to these tests EUA status, the cost may be submitted to insurance for reimbursement. Learn more about FDA Emergency Use Authorization testing.